Metabolic‐associated fatty liver disease is associated with severity of COVID‐19

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

(2020) Renhong Yan et al.   SCIENCE

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China

(2020) Yafei Zhang et al.   LIVER INTERNATIONAL

Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease

(2019) Xi Cao et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Obesity and Overweight in Asian People

(2016) Akiko Goda et al.   CIRCULATION JOURNAL

The Immune Landscape in Nonalcoholic Steatohepatitis

(2016) Sowmya Narayanan et al.   Immune Network

Diagnosis of Diabetes Mellitus Using HbA1c in Asians: Relationship Between HbA1c and Retinopathy in a Multiethnic Asian Population

(2015) Charumathi Sabanayagam et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The role of renin-angiotensin system modulation on treatment and prevention of liver diseases

(2014) Simone Moreira de Macêdo et al.   PEPTIDES

Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study

(2012) Irfan Zeb et al.   ACADEMIC RADIOLOGY

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION